Emerald Bioventures, LLC
SEC insider (Form 3/4/5 filer). CIK 0002020620. 10% Owner at Galera Therapeutics, Inc. (GRTX). 1 reported Form 4/5 transaction since Sep 2024; latest on May 15, 2026. Located in NEW YORK, NY.
Companies Emerald Bioventures, LLC has filed insider reports for
- Galera Therapeutics, Inc. (GRTX): 10% Owner
Emerald Bioventures, LLC
CIK: 0002020620
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (100.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
GRTX
Galera Therapeutics, Inc.
10% Owner